Andere talen Roquefort Therapeutics plc

Aandelen

ROQ

GB00BMDQ2T15

Vertraagde tijd London S.E. Andere beurzen 14:20:17 24-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
4,344 ^GBX	-1,27%		-3,47%	-40,08%

23/05	Windward wint deal; Kodal boekt vooruitgang bij Bougouni	AN
23/05	Roquefort Therapeutics plc kondigt wijzigingen aan in de Executive en Board	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Windward wins deal; Kodal progresses at Bougouni	23/05
Roquefort Therapeutics plc Announces Executive and Board Changes	23/05
EARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters Germany	26/04
Earnings Flash (ROQ.L) ROQUEFORT THERAPEUTICS Reports FY23 Loss GBX-1.35	26/04
Roquefort Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023	26/04
Roquefort cancels fundraise after "unusual" stock movements	05/04
Roquefort Therapeutics Shelves Potential Placing Following Unusual Price Movements	05/04
Roquefort celebrates "significant milestones" in cancer research	11/03
Roquefort Therapeutics plc Provides an Update on the Development of the Midkine Midkine mRNA and STAT-6 siRNA programs	11/03
Roquefort Therapeutics plc - Operations Update	07/02
Roquefort hails further MK studies, licence talks continue	06/02
Roquefort Therapeutics plc Provides an Update on Its Pre-Clinical Drug Development Programs	06/02
Roquefort Therapeutics Announces Significant Mesodermal Killer Cell Milestone	06/11
EARNINGS: Biome loss widens; Amicorp focused on growth post-IPO	27-09-23
Roquefort Therapeutics plc Reports Earnings Results for the Half Year Ended June 30, 2023	27-09-23
Roquefort Therapeutics seeks to lock in future value with anti-cancer therapeutic patents	15-08-23
Roquefort files patent application for mRNA and RNA therapies	14-08-23
Roquefort Therapeutics Files International Patent for Anti-cancer Therapeutics	14-08-23
Roquefort Therapeutics plc Announces the Successful Filing of the International Phase PCT Patent for Its Proprietary Anti-Cancer mRNA and RNA Oligonucleotide Therapeutics	14-08-23
Roquefort Therapeutics making headway with siRNA	09-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Roquefort Therapeutics plc

Aandelen

ROQ

GB00BMDQ2T15

Andere talen

Filters